The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Editas Medicine Inc’s stock clocked out at $5.72, down -4.03% from its previous closing price of $5.96. In other words, the price has decreased by -$4.03 from its previous closing price. On the day, 1.79 million shares were traded. EDIT stock price reached its highest trading level at $5.905 during the session, while it also had its lowest trading level at $5.49.
Ratios:
To gain a deeper understanding of EDIT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.60 and its Current Ratio is at 4.60. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.07.
On October 24, 2023, Citigroup Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $11.
JP Morgan Upgraded its Underweight to Neutral on October 18, 2023, while the target price for the stock was maintained at $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 04 ’24 when O’Neill Gilmore Neil sold 12,191 shares for $5.50 per share. The transaction valued at 66,997 led to the insider holds 315,279 shares of the business.
Mei Baisong sold 511 shares of EDIT for $2,808 on Jun 04 ’24. The EVP, CHIEF MEDICAL OFFICER now owns 141,032 shares after completing the transaction at $5.50 per share. On May 20 ’24, another insider, Lucera Erick, who serves as the EVP, CHIEF FINANCIAL OFFICER of the company, sold 22,337 shares for $5.61 each. As a result, the insider received 125,404 and left with 116,829 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 490138176 and an Enterprise Value of 208369216. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.78 while its Price-to-Book (P/B) ratio in mrq is 1.60. Its current Enterprise Value per Revenue stands at 3.002 whereas that against EBITDA is -1.162.
Stock Price History:
The Beta on a monthly basis for EDIT is 2.04, which has changed by -0.34777653 over the last 52 weeks, in comparison to a change of 0.23228896 over the same period for the S&P500. Over the past 52 weeks, EDIT has reached a high of $11.69, while it has fallen to a 52-week low of $4.45. The 50-Day Moving Average of the stock is 7.41%, while the 200-Day Moving Average is calculated to be -23.00%.
Shares Statistics:
It appears that EDIT traded 2.13M shares on average per day over the past three months and 1697760 shares per day over the past ten days. A total of 81.77M shares are outstanding, with a floating share count of 81.53M. Insiders hold about 0.86% of the company’s shares, while institutions hold 78.68% stake in the company. Shares short for EDIT as of 1719532800 were 16743787 with a Short Ratio of 7.87, compared to 1717113600 on 22019551. Therefore, it implies a Short% of Shares Outstanding of 16743787 and a Short% of Float of 25.81.
